幹細胞臍帯血(UCB)の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Stem Cell Umbilical Cord Blood Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Process of Collection, Processing, and Storage of Cord Blood Cells
06.1 Donor Evaluation
06.2 Collection Methods
06.3 Processing and Storage Methods
06.4 Sample Retention and Length of Storage

07.Facts: Cord Blood Units

08.US FDA Approved Stem Cell UCB Product
08.1 Hemacord
08.1.1 Mechanism of Action
08.1.2 Side Effects

09.Pipeline Analysis
09.1 Information on Pipeline Candidates
09.1.1 PDA-002
09.1.2 PDA-001
09.1.3 PLX-PAD
09.1.4 PLX-R18

10.Market Landscape
10.1 Market Overview
10.2 Market Size and Forecast
10.3 Five Forces Analysis

11.Market Segmentation by Application
11.1 Cancers
11.2 Blood Disorders
11.3 Metabolic Disorders
11.4 Immune Disorders
11.5 Others

12.Market Segmentation by Storage
12.1 Public Cord Blood Bank
12.2 Private Cord Blood Bank
12.3 Public-Private Cord Blood Banks

13.Harmonization of Biobanking

14.Market Segmentation by End-user
14.1 Research Institutes
14.2 Pharmaceutical Companies
14.3 Biobanks
14.4 Hospitals

15.Geographical Segmentation
15.1 Stem Cell UCB Market in Americas
15.1.1 Market Size and Forecast
15.2 Stem Cell UCB Market in EMEA
15.2.1 Market Size and Forecast
15.3 Stem Cell UCB Market in APAC
15.3.1 Market Size and Forecast

16.Buying Criteria

17.Market Growth Drivers

18.Drivers and their Impact

19.Market Challenges

20.Impact of Drivers and Challenges

21.Market Trends

22.Trends and their Impact

23.Vendor Landscape
23.1 Competitive Scenario
23.1.1 Key News
23.1.2 Mergers and Acquisitions
23.2 Market Share Analysis 2014
23.2.1 Caladrius Biosciences
23.2.2 Celgene Corp.
23.2.3 Mesoblast Ltd.
23.2.4 Pluristem Therapeutics
23.3 Other and Future Prominent Vendors

24.Global Stem Cell UCB Market: Key Takeaways

25.Key Vendor Analysis
25.1 Caladrious
25.1.1 Key Facts
25.1.2 Business Overview
25.1.3 Business Segmentation by Revenue 2014
25.1.4 Business Segmentation by Revenue 2013 and 2014
25.1.5 Geographical Segmentation by Revenue 2014
25.1.6 Business Strategy
25.1.7 Recent Developments
25.1.8 SWOT Analysis
25.2 Celgene
25.2.1 Key Facts
25.2.2 Business Overview
25.2.3 Business Strategy
25.2.4 Business Segmentation by Revenue
25.2.5 Sales by Geography
25.2.6 Key Information
25.2.7 SWOT Analysis
25.3 Mesoblast
25.3.1 Key Facts
25.3.2 Business Overview
25.3.3 Therapeutic Areas
25.3.4 Geographical Segmentation
25.3.5 Business Strategy
25.3.6 Recent Developments
25.3.7 SWOT Analysis
25.4 Pluristem
25.4.1 Key Facts
25.4.2 Business Overview
25.4.3 Geographical Presence
25.4.4 Business Strategy
25.4.5 Recent Developments
25.4.6 SWOT Analysis

26.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Donor Evaluation before Collection of Cord Blood Cells
Exhibit 3: Collection of Cord Blood Cells
Exhibit 4: Processing and Storage Methods of Cord Blood Cells
Exhibit 5: Stem Cell Transplantations by Patient Race in US
Exhibit 6: Pipeline Portfolio of Stem Cell UCB Products for Different Diseases
Exhibit 7: Global Stem Cell UCB Market 2014-2019 ($ millions)
Exhibit 8: Global Stem Cell UCB Market Segment by Application
Exhibit 9: Global Stem Cell UCB Market Segmentation by Storage
Exhibit 10: Organizations and Initiatives Toward Biobank Harmonization
Exhibit 11: Key Factors Involved in Harmonization of Biobanks
Exhibit 12: Key Focus Areas in Harmonization of Biobanks
Exhibit 13: Organizations and Initiatives in Harmonizing Science and Infrastructure
Exhibit 14: Initiatives on Biobanking Resource Tools and Databases
Exhibit 15: Global Stem Cell UCB Market Segment by End-user
Exhibit 16: Segmentation of Global Stem Cell UCB Market by Geography 2014
Exhibit 17: Stem Cell UCB Market in Americas 2014-2019 ($ millions)
Exhibit 18: Stem Cell UCB Market in APAC 2014-2019 ($ millions)
Exhibit 19: Stem Cell UCB Market in APAC 2014-2019 ($ millions)
Exhibit 20: Statistics of Stem Cell UCB Market by Geography
Exhibit 21: Global Stem Cell UCB Market: Key Takeaways
Exhibit 22: Caladrious: Business Segmentation by Revenue 2014
Exhibit 23: Caladrious: Business Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 24: Caladrious: Geographical Segmentation by Revenue 2014
Exhibit 25: Celgene: Business Segmentation by Revenue 2011-2013 ($ millions)
Exhibit 26: Celgene: Sales by Geography 2013
Exhibit 27: Mesoblast: Therapeutic Areas
Exhibit 28: Mesoblast: Geographical Segmentation
Exhibit 29: PLuristem: Geographical Presence


【レポート販売概要】

■ タイトル:幹細胞臍帯血(UCB)の世界市場2015-2019
■ 英文:Global Stem Cell Umbilical Cord Blood Market 2015-2019
■ 発行日:2015年8月19日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6649
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。